Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AA Amyloidosis: recent knowledges on pathophysiology].

N Magy1

  • 1Service de médecine interne et immunologie clinique, CHU Jean-Minjoz, Besançon, France. nmagy@chu-besancon.fr

La Revue De Medecine Interne
|January 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pronostic value of C-reactive protein measure in elderly patient with acquired pneumonia: correlation with Fine's score].

La Revue de medecine interne·2007
Same author

[Aspergillosis in systemic diseases treated with steroids and/or immunosuppressive drugs: report of 9 cases and review of the literature].

La Revue de medecine interne·2006
Same author

Priapism related to an antiphospholipid syndrome in a patient with systemic lupus erythematosus.

Clinical and experimental rheumatology·2006
Same author

Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases.

Lupus·2006
Same author

[Influenza vaccination among health-care workers. Vaccination rates in universitary hospital of Besançon, winter 2003-2004].

La Revue de medecine interne·2005
Same author

[Protein Z: a new factor of thrombophilia?].

La Revue de medecine interne·2005
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Amyloidosis, a rare disease, is being studied for its pathophysiology, particularly AA amyloidosis. Research explores inhibitors and treatments like anti-P component, showing promise for human amyloidosis.

Area of Science:

  • Rare diseases
  • Pathology
  • Biochemistry

Context:

  • Amyloidosis diagnosis requires pathological identification of extracellular deposits.
  • Over 20 proteins can form amyloid fibrils, with AA and AL amyloidosis being common.
  • Transthyretin amyloidosis is the most prevalent genetic form.

Purpose:

  • Investigate amyloidosis pathophysiology, focusing on AA amyloidosis.
  • Understand the cellular mechanisms and components involved in amyloid formation.
  • Identify potential therapeutic targets and treatments for amyloidosis.

Summary:

  • Extracellular amyloid formation can occur without macrophages, initiated by amyloid-enhancing factor.
  • Research is ongoing to discover inhibitors of intra- and extracellular amyloid formation.

Related Experiment Videos

  • Anti-P component therapy shows promise, successfully treating murine AA amyloidosis.

    • Impact:

    • Advances understanding of amyloidosis pathogenesis.
    • Identifies potential therapeutic strategies for human amyloidosis.
    • Highlights the need for further research into amyloid inhibitors and treatments.